Bioventix (LON:BVXP) Stock Price Crosses Below 200 Day Moving Average – Time to Sell?

Shares of Bioventix PLC (LON:BVXP) passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 1,690.45 and traded as low as GBX 1,600. Bioventix shares last traded at GBX 1,700, with a volume of 2,422 shares.

Bioventix Price Performance

The stock has a market cap of £88.83 million, a price-to-earnings ratio of 12.10 and a beta of 0.55. The company’s fifty day moving average price is GBX 1,682.18 and its 200-day moving average price is GBX 1,690.45.

Bioventix (LON:BVXP) last released its earnings results on Monday, March 30th. The biotechnology company reported GBX 69.38 EPS for the quarter. The company had revenue of GBX 615.88 billion during the quarter. Bioventix had a net margin of 59.30% and a return on equity of 65.83%. On average, sell-side analysts forecast that Bioventix PLC will post 166.3066955 earnings per share for the current fiscal year.

Insider Activity at Bioventix

In other news, insider Ian James Nicholson bought 1,000 shares of Bioventix stock in a transaction that occurred on Friday, April 10th. The stock was bought at an average price of GBX 1,848 per share, for a total transaction of £18,480. Also, insider Bruce Hiscock purchased 534 shares of the stock in a transaction on Wednesday, June 24th. The shares were purchased at an average cost of GBX 1,799 per share, with a total value of £9,606.66. Insiders have bought a total of 2,665 shares of company stock valued at $4,888,665 in the last ninety days. Company insiders own 6.22% of the company’s stock.

About Bioventix

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.